• LAST PRICE
    6.7000
  • TODAY'S CHANGE (%)
    Trending Down-0.1000 (-1.4706%)
  • Bid / Lots
    6.2000/ 1
  • Ask / Lots
    7.1100/ 1
  • Open / Previous Close
    6.6400 / 6.8000
  • Day Range
    Low 6.4300
    High 7.0300
  • 52 Week Range
    Low 1.9750
    High 18.6112
  • Volume
    18,458
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.8
TimeVolumeOMGA
09:32 ET12156.43
10:49 ET1006.51
10:51 ET23926.7599
10:54 ET4306.79
10:56 ET21996.825
10:58 ET2006.8
11:00 ET5006.78
11:02 ET3106.9
11:03 ET2006.81
11:05 ET9646.68
11:07 ET1006.84
11:09 ET10016.8
12:06 ET1006.75
12:08 ET3286.735
12:57 ET3726.5
01:00 ET19526.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOMGA
Omega Therapeutics Inc
321.9M
-3.5x
---
United StatesALDX
Aldeyra Therapeutics Inc
319.7M
-4.9x
---
United StatesPRLD
Prelude Therapeutics Inc
326.4M
-2.7x
---
United StatesAADI
Aadi Bioscience Inc
324.9M
-4.5x
---
United StatesOCGN
Ocugen Inc
330.5M
-4.3x
---
United StatesHUMA
Humacyte Inc
326.9M
9.6x
---
As of 2022-11-26

Company Information

Omega Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is engaged in a systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programming platform. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth, and differentiation to cell death. It has deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains (IGDs). The OMEGA platform enables to systematically identify and validate thousands of DNA-sequence-based epigenomic zip codes within IGDs. Its pipeline consists of early-stage, preclinical programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases.

Contact Information

Headquarters
20 Acorn Park DriveCAMBRIDGE, MA, United States 02140
Phone
617-949-4360
Fax
302-655-5049

Executives

Chairman of the Board, Co-Founder
Noubar Afeyan
President, Chief Executive Officer, Director
Mahesh Karande
Chief Financial Officer
Joshua Reed
Chief Human Resource Officer
Kevin McManus
Chief Legal and Administrative Officer, Company Secretary
Ling Zeng

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$321.9M
Revenue (TTM)
$1.3M
Shares Outstanding
48.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.94
Book Value
$4.20
P/E Ratio
-3.5x
Price/Sales (TTM)
240.4
Price/Cash Flow (TTM)
---
Operating Margin
-6,916.06%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.